Literature DB >> 23300056

Determination of key receptor-ligand interactions of dopaminergic arylpiperazines and the dopamine D2 receptor homology model.

Vladimir Sukalovic1, Vukic Soskic, Milan Sencanski, Deana Andric, Sladjana Kostic-Rajacic.   

Abstract

Interest in structure-based G-protein-coupled receptor (GPCR) ligand discovery is huge, given that almost 30 % of all approved drugs belong to this category of active compounds. The GPCR family includes the dopamine receptor subtype D2 (D2DR), but unfortunately--as is true of most GPCRs--no experimental structures are available for these receptors. In this publication, we present the molecular model of D2DR based on the previously published crystal structure of the dopamine D3 receptor (D3DR). A molecular modeling study using homology modeling and docking simulation provided a rational explanation for the behavior of the arylpiperazine ligand. The observed binding modes and receptor-ligand interactions provided us with fresh clues about how to optimize selectivity for D2DR receptors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23300056     DOI: 10.1007/s00894-012-1731-6

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  26 in total

1.  Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist.

Authors:  Ellen Y T Chien; Wei Liu; Qiang Zhao; Vsevolod Katritch; Gye Won Han; Michael A Hanson; Lei Shi; Amy Hauck Newman; Jonathan A Javitch; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-11-19       Impact factor: 47.728

2.  Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design.

Authors:  David E Gloriam; Steven M Foord; Frank E Blaney; Stephen L Garland
Journal:  J Med Chem       Date:  2009-07-23       Impact factor: 7.446

3.  A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice.

Authors:  J A Javitch; J A Ballesteros; H Weinstein; J Chen
Journal:  Biochemistry       Date:  1998-01-27       Impact factor: 3.162

4.  Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method.

Authors:  J A Javitch; D Fu; J Chen; A Karlin
Journal:  Neuron       Date:  1995-04       Impact factor: 17.173

5.  Molecular determinants of selectivity and efficacy at the dopamine D3 receptor.

Authors:  Amy Hauck Newman; Thijs Beuming; Ashwini K Banala; Prashant Donthamsetti; Katherine Pongetti; Alex LaBounty; Benjamin Levy; Jianjing Cao; Mayako Michino; Robert R Luedtke; Jonathan A Javitch; Lei Shi
Journal:  J Med Chem       Date:  2012-06-07       Impact factor: 7.446

6.  CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields.

Authors:  K Vanommeslaeghe; E Hatcher; C Acharya; S Kundu; S Zhong; J Shim; E Darian; O Guvench; P Lopes; I Vorobyov; A D Mackerell
Journal:  J Comput Chem       Date:  2010-03       Impact factor: 3.376

7.  The association of the dopamine transporter gene and the dopamine receptor 2 gene with delirium, a meta-analysis.

Authors:  Barbara C van Munster; Sophia E J A de Rooij; Mojgan Yazdanpanah; Pentti J Tienari; Kaisu H Pitkälä; Robert J Osse; Dimitrios Adamis; Orla Smit; Marijke S van der Steen; Miriam van Houten; Terhi Rahkonen; Raimo Sulkava; Jouko V Laurila; Timo E Strandberg; Joke H M Tulen; Louwerens Zwang; Alastair J D MacDonald; Adrian Treloar; Eric J G Sijbrands; Aeilko H Zwinderman; Johanna C Korevaar
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

8.  Homology modeling of the dopamine D2 receptor and its testing by docking of agonists and tricyclic antagonists.

Authors:  M M Teeter; M Froimowitz; B Stec; C J DuRand
Journal:  J Med Chem       Date:  1994-09-02       Impact factor: 7.446

9.  N-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists.

Authors:  Amy Hauck Newman; Peter Grundt; George Cyriac; Jeffrey R Deschamps; Michelle Taylor; Rakesh Kumar; David Ho; Robert R Luedtke
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

10.  Ligand discovery from a dopamine D3 receptor homology model and crystal structure.

Authors:  Jens Carlsson; Ryan G Coleman; Vincent Setola; John J Irwin; Hao Fan; Avner Schlessinger; Andrej Sali; Bryan L Roth; Brian K Shoichet
Journal:  Nat Chem Biol       Date:  2011-09-18       Impact factor: 15.040

View more
  1 in total

1.  Comparative molecular field analysis and molecular dynamics studies of the dopamine D2 receptor antagonists without a protonatable nitrogen atom.

Authors:  Agnieszka A Kaczor; Justyna Żuk; Dariusz Matosiuk
Journal:  Med Chem Res       Date:  2018-02-13       Impact factor: 1.965

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.